Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Hypertension Diagnostics Inc (HDII) -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (21)	8/16/2000 9:21:56 PM
From: scott_jiminez	Respond to of 120

Well Dr. Jiminez, that was quite a prescient post. If we could tear William O'Neil away from his duties as chief mudslinger at the Barry Goldwater for God committee, he'd frame that chart for his IBD archives. Classic cup with handle...suggestive that we remain in the nascent stages of a big time rally.

To: scott_jiminez who wrote (21)	9/2/2000 9:18:45 PM
From: smh	Read Replies (1) \| Respond to of 120

Scott, An interesting monologue you have going here. You got my attention recently with a post on another thread pointing out the classic cup and handle HDII had going. I'm no TA expert, but that formation looks nearly perfect. Too bad it didn't hold up... might have become the textbook case. Beyond the C&H there were several things about this stock which intrigued me. I have often thought how utterly absurd it is that blood pressure and cholesterol levels are the only clues most of us have about the condition of our CV system. We go merrily along until we have chest pain, or worse, in spite of the statistical evidence that there probably is serious deterioration in progress. As an engineer, the concept of monitoring as many of the dynamic performance parameters of this critical system is almost obvious. In fact, developing the apparatus to accomplish the task does not appear to me to be exceptionally challenging. So, one of the things I looked for in the 10K was the strength of their IP position. Unfortunately, I didn't find much. Although I have not yet reviewed their patents it is hard to imagine that either their method of analysis or any other part of their product provide much protection or competitive advantage. Before you get the impression that I am a basher let me hasten to add that I actually bought a token number of warrants a few days ago (before any DD) and would very much like to be convinced to buy more. I was also looking for some indication of increasing demand from the research community. Again, nothing at all obvious. Lastly, there sounds to be significant competition on the wings. What do you know of the "Complior" technology and/or the French co. which owns it? I would be happy to hear any positives relative to the above issues, if you are so inclined. Regards SMH